Liver disease is on the rise in the United States. Women are at a higher risk of developing a certain type of liver disease called Primary Biliary Cholangitis, ...

Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

Zurich (Switzerland), May 20, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients ...

We are looking at what kind of products, diagnostics or other solutions we can offer to become a well-rounded player in a ...

At close: May 16 at 4:00:00 PM EDT ...